The Patent Finder

Actavis Holdco US, Inc.

Also on record
Records under this name other than the patents Actavis Holdco US, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 10 of 10 · Back to Actavis Holdco US, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,785,627Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Term ended
Term ended Jul 31, 2026 · USPTO record
Term endedTerm ended Jul 31, 2026USPTO record
US 8,470,368Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Term ended
Term ended Nov 1, 2023 · USPTO record
Term endedTerm ended Nov 1, 2023USPTO record
US 8,309,125Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Term ended
Ended no later than Sep 19, 2023 · USPTO record
Term endedEnded no later than Sep 19, 2023USPTO record
US 8,668,931Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Term ended
Ended no later than Sep 19, 2023 · USPTO record
Term endedEnded no later than Sep 19, 2023USPTO record
US 6,630,166Compositions for conjugated estrogens and associated methods
Term ended
Term ended Feb 12, 2022 · USPTO record
Term endedTerm ended Feb 12, 2022USPTO record
US 8,597,683Modified release tranexamic acid formulation
Lapsed on the fee record
Ended Dec 3, 2021 · USPTO record
Lapsed on the fee recordEnded Dec 3, 2021USPTO record
US 9,387,178Modified release tranexamic acid formulation
Lapsed on the fee record
Ended Jul 12, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 12, 2020USPTO record
US 6,180,133Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
Term ended
Term ended Nov 24, 2018 · USPTO record
Term endedTerm ended Nov 24, 2018USPTO record
US 8,309,104Oral controlled release formulation for sedative and hypnotic agents
Lapsed on the fee record
Ended Nov 13, 2016 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2016USPTO record
US D440,650Tablet
Term ended
Term ended Apr 17, 2015 · USPTO record
Term endedTerm ended Apr 17, 2015USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited